3.0 Credits - CME/CPE | Expires 12/15/2015
The activity is supported by educational grants from AbbVie Inc, Astellas Scientific and Medical Affairs, Inc, and Janssen Biotech, Inc., and administered by Janssen Scientific Affairs, LLC, and sanofi-aventis US.
Robert Dreicer, MD, MS, FACP, FASCO
Director, GU Medical Oncology
Taussig Cancer Institute
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Deputy Associate Director of Clinical Research
Case Comprehensive Cancer Center
Michael Kolodziej, MD, FACP
National Medical Director
Neal Shore, MD, FACS
Carolina Urologic Research Center (CURC)
Atlantic Urology Clinics
Myrtle Beach, South Carolina
Prostate cancer is the most common cancer and the second-leading cause of death among men in the United States. It is associated with significant clinical and economic burden. This supplement is intended to provide a clinical understanding of prostate cancer, discuss current, new, and evolving treatment strategies for early-stage, recurrent, and advanced prostate cancer, and discuss the economic burden of the disease.
Upon completion of this activity, participants should be able to:
Managed care clinicians and administrators, including physicians, pharmacists, medical and formulary directors, and other managed care professionals involved in the care of patients with prostate cancer.
Release date: December 15, 2014
Expiration date: December 15, 2015
Estimated time to complete activity: 3.0 hours
Type of activity: Knowledge
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accredita­ tion Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Pharmacy Times Office of Continuing Professional Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this journal-based activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (0.30 CEUs) under the ACPE universal activity number UAN 0290-9999-14-108-H01-P. The activity is available for CE credit through December 15, 2015.
Participants must take the pretest, read the journal supplement, and complete the online posttest achieving a passing score of 70% or higher. Once the posttest is submitted each participate will need to complete and submit the online activity evaluation and request their credit before the activity expires on December 15, 2015.
For Physician credit (CME) only
For Pharmacy credit (CPE) only
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Required: Mac OS® X 10.4.11 (Tiger®) or newer
For questions about this Internet CPE activity, please contact: email@example.com.